glp 1 b12 injections GLP-1 with Vitamin *Purchasing the program does not qualify a patient for treatment GLP-1/GIP + B12

Rather than acting solely through weight loss or peripheral glucose control, GLP-1 therapies engage neural pathways involved in energy regulation, inflammation, synaptic integrity, and protein homeostasisoffering a biologically coherent explanation for their emerging association with preserved cognitive function and reduced dementia risk

65% of patients achieved more than 10% weight loss compared to 0% placebo

In people with DKD, the once-weekly GLP-1 receptor agonist dulaglutide increased mGFR (37), although semaglutide appeared to initially reduce eGFR (15)

Within three months, Sarah had lost about 17 pounds, and by the six-month mark, her total weight loss reached 25 pounds